juli is an AI-powered digital health platform that helps patients and their care teams manage complex chronic conditions by analyzing behavioral patterns and pinpointing triggers that can worsen symptoms. Led by CEO and co-founder Bettina Hein and CMO Bettina Duehrkoop, the app provides insights to identify changes that can help avoid or alleviate flare-ups. Since launching a year ago, approximately 15,000 patients have used the app to track data for chronic, debilitating conditions. The company plans to use the funds to scale its commercial team across the U.S., conduct clinical trials of the app, and acquire additional AI talent. juli is based in Boston, MA.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2022